At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and treatment burden in patients ...
NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a company developing ...
Johnson & Johnson (JNJ) stock is in focus as the company's Erda-iDRS drug delivery system hits the main goal in a Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results